To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Ketorolac vs. Depomedrol Injections for Subacromial Impingement

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2022

Ketorolac vs. Depomedrol Injections for Subacromial Impingement

Vol: 228| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Outcomes of ketorolac versus depomedrol infiltrations for subacromial impingement syndrome: a randomized controlled trial

Musculoskelet Surg . 2022 Mar;106(1):29-34.

Contributing Authors:
T Goyal S Paul SS Sethy AK Choudhury

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Seventy patients with subacromial impingement syndrome were randomized to receive a subacromial depomedrol injection (n=35) or a subacromial ketorolac injection (n=35). The outcomes of interest included pain, function and range of motion at one and three month follow-up. There was no significant differences in pain as measured by a visual analogue scale. No differences in function between the two ...

Join the Conversation

Please Login or Join to leave comments.